<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00388050</url>
  </required_header>
  <id_info>
    <org_study_id>06-003513</org_study_id>
    <secondary_id>ADA #33</secondary_id>
    <nct_id>NCT00388050</nct_id>
  </id_info>
  <brief_title>Diabetes Medication Choice</brief_title>
  <official_title>Wiser Choices for Patients With Type II Diabetes: Diabetes Medication Choice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Diabetes Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine how different ways of sharing information about
      diabetes medication treatment options with patients can affect their choices and health.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Understanding</measure>
    <time_frame>Directly proceeding the clinical encounter</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Decisional Conflict</measure>
    <time_frame>Directly proceeding the clinical visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Action, adherence</measure>
    <time_frame>Directly proceeding the clinical encounter, 6 months after the clinical encounter</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trust</measure>
    <time_frame>Directly proceeding the clinical visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability</measure>
    <time_frame>Directly proceeding the clinical encounter</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">85</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Diabetes Medication Choice decision aid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will discuss diabetes medication for glucose control with the help of a decision aid that covers five commonly prescribed anti-hyperglycemic medications.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes Medication Choice decision aid</intervention_name>
    <description>The decision aid covers five commonly prescribed anti-hyperglycemic medications and their attributes.</description>
    <arm_group_label>Diabetes Medication Choice decision aid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not
             required

          -  Use 1 or 2 oral hypoglycemic agents; not using insulin therapy

          -  Are not pregnant

          -  Have stable but inadequate glycemic control: both A1C at the time of eligibility and
             previous A1c within 6 months between 7-9.5%

          -  Recognize their primary care provider as their main diabetes care provider

          -  Do not have major barriers (i.e., severe hearing impairment, dementia, cannot
             communicate in English) to participate in shared decision-making (per provider?s
             assessment)

          -  Have no plans to relocate out of town in the next 6 months

          -  Enrolment is open to males and females of diverse racial backgrounds
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor M. Montori, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2006</study_first_submitted>
  <study_first_submitted_qc>October 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2006</study_first_posted>
  <last_update_submitted>April 27, 2015</last_update_submitted>
  <last_update_submitted_qc>April 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2015</last_update_posted>
  <responsible_party>
    <name_title>Victor Montori</name_title>
    <organization>Mayo Clini</organization>
  </responsible_party>
  <keyword>Decision aid, diabetes, primary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

